Financials
Income statement
| Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 94.9B | 85.8B | 90.8B | 119.6B |
| Cost of revenue | 51.1B | 46.1B | 48.5B | 64.7B |
| Gross profit | 43.9B | 39.7B | 42.3B | 54.9B |
| Operating expense | ||||
| Research & development | 7.8B | 8.0B | 7.9B | 7.7B |
| Selling general and admin | 6.5B | 6.3B | 6.5B | 6.8B |
| Other operating expenses | — | — | — | — |
| Operating income | 29.6B | 25.4B | 27.9B | 40.4B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 19M | 142M | 158M | -50M |
| Pretax income | 29.6B | 25.5B | 28.1B | 40.3B |
| Tax provision | 14.9B | 4.0B | 4.4B | 6.4B |
| Net income | 14.7B | 21.4B | 23.6B | 33.9B |
| Basic EPS | 1.0 | 1.4 | 1.5 | 2.2 |
| Diluted EPS | 1.0 | 1.4 | 1.5 | 2.2 |
| Basic average shares | 15.2B | 15.3B | 15.4B | 15.5B |
| Diluted average shares | 15.2B | 15.3B | 15.5B | 15.6B |
| EBITDA | 32.5B | 28.2B | 30.7B | 43.2B |
| Net income from continuing op. | 14.7B | 21.4B | 23.6B | 33.9B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |